Shield Bio
DefunctYC S16San Francisco, US · 28 employees · 5 known investors
Find your way into Shield Bio
10,404 people in our graph share verified history with the Shield Bio team — schools, employers, funds. One of them is your warm intro.
Hemant Tanejaunlockedknows Fred Turner · together at Y Combinator (overlapped)
knows the team · via University of Oxford
×10knows the team · via Y Combinator
Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.
Also known as Shield Diagnostics · TL Biolabs
Founders & leadership· Y Combinator alumni (S16)
FT
Fred TurnerFounder · CEO2018–2020Fred Turner is founder and CEO of Shield Bio, which develops nanopore sequencing technology for rapid genetic testing in clinical settings, with an initial focus on infectious disease and sepsis detection.
Investors · 5
Founder mafia
2 people who came through Shield Bio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Shield Bio do?
- Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.
- Who founded Shield Bio?
- Shield Bio was founded by Fred Turner.
- Who are Shield Bio's investors?
- Shield Bio's investors include Y Combinator, Andreessen Horowitz, Refactor Capital, Soma Capital, Valia Ventures.
- Where is Shield Bio headquartered?
- Shield Bio is headquartered in San Francisco, US.